AnodyneWiki

Phenobarbital

Phenobarbital
Phenobarbital
Salts
[]
Sodium phenobarbital
Sodium phenobarbital
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass232.23 g/mol [1]
AppearanceCrystals (3 different phases) [1]
OdorOdorless [1]
TasteSlightly bitter taste [1]
Melting point345 to 352 °F (NTP, 1992) [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1]
Solubilityless than 0.1 mg/mL at 57 °F (NTP, 1992) [1]
Predicted LogP1.5 [1]
Structural Identifiers
[]
Molecular formulaC12H12N2O3
IUPAC name5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
SMILESCCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
InChIInChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)
InChIKeyDDBREPKUVSBGFI-UHFFFAOYSA-N
CAS number50-06-6
UNIIYQE403BP4D
PubChem CID4763
Pharmacokinetics[]
OnsetWithin 5 min (IV); 30 min (PO)
Elimination half-life53–118 hours
Duration of action4 hours–2 days
MetabolismLiver (mostly CYP2C19)
ExcretionKidney and fecal
Routes of administrationBy mouth, rectal, parenteral, intramuscular, intravenous[3][4]
Dependence liabilityHigh[5]
Toxicity
[]
Rat:
- oral: 162 +/-
- oral: 660 mg/kg /Sodium
- ip: 151 mg/kg
- sc: 200 mg/kg
 [1]

Phenobarbital (also known as Phenobarbitone, Luminal, Phenobarbitol, Fenobarbital, Nunol, Phenylethylbarbiturate, Dormiral, Gardenal, Gardepanyl or Neurobarb) is a substance of the barbiturate class.

Chemistry

Salts []

Phenobarbital is typically found in the form of its sodium salt.

 []

Phenobarbital is achiral.

Phenobarbital matches Lipinski's rule of five.

There are currently 2 reagent-interactions on

ReagentColor changeDescription
Marquisno color change
Meckeno color change

Pharmacology

Mechanism of action []

Phenobarbital acts on GABAA receptors, increasing synaptic inhibition. This has the effect of elevating seizure threshold and reducing the spread of seizure activity from a seizure focus. Phenobarbital may also inhibit calcium channels, resulting in a decrease in excitatory transmitter release. The sedative-hypnotic effects of phenobarbital are likely the result of its effect on the polysynaptic midbrain reticular formation, which controls CNS arousal. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

induction177 (15 contraindicated)
induction81 (1 contraindicated)
shared target64
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
shared target61
induction37 (1 contraindicated)

Medical side effects []

80 side effects listed on drug labels in (phenobarbital).

  • Congenital anomaly
  • Developmental delay
  • Anaemia megaloblastic
  • Angioedema
  • Apnoea
  • Asthma
  • Ataxia
  • Blister
  • Dermatitis bullous
  • Coma
  • Confusional state
  • Feeling abnormal
  • Constipation
  • Delirium
  • Dermatitis
  • Rash
  • Dermatitis exfoliative
  • Dizziness
  • Syncope
  • Somnolence
  • Localised oedema
  • Emotional disorder
  • Toxic epidermal necrolysis
  • Extravasation
  • Body temperature increased
  • Folate deficiency
  • Hallucination
  • Headache
  • Hepatitis
  • Hypersensitivity
  • Hypocalcaemia
  • Hypotension
  • Body temperature decreased
  • Hypothermia
  • Irritability
  • Laryngospasm
  • Lethargy
  • Nausea
  • Necrosis
  • Nervousness
  • Tension
  • Nightmare
  • Nystagmus
  • Osteomalacia
  • Pain
  • Renal failure
  • Shock
  • Erythema multiforme
  • Stevens-Johnson syndrome
  • Loss of consciousness
  • Erythema
  • Urticaria
  • Vertigo
  • Vitamin K deficiency
  • Vomiting
  • Agitation
  • Excitement
  • Hyperkinesia
  • Mood swings
  • Affect lability
  • Depressed level of consciousness
  • Injection site reaction
  • Hepatocellular injury
  • Liver injury
  • Hangover
  • Myalgia
  • Musculoskeletal discomfort
  • Thinking abnormal
  • Mental disability
  • Respiratory depression
  • Pulmonary function test decreased
  • Anxiety
  • Phobia
  • Suicidal ideation
  • Bradycardia
  • Arthralgia
  • Suicidal behaviour
  • Hypoxia
  • Respiratory failure
  • Hypoventilation

Indications

  • Anxiety
  • Cardiac failure
  • Cerebral haemorrhage
  • Cholera
  • Chorea
  • Convulsion
  • Eclampsia
  • Epilepsy
  • Essential hypertension
  • Excitability
  • Febrile convulsion
  • Haemorrhage
  • Hyperthyroidism
  • Insomnia
  • Labyrinthitis
  • Meningitis
  • Motion sickness
  • Nausea
  • Partial seizures
  • Pylorospasm
  • Status epilepticus
  • Tension
  • Tetanus
  • Vomiting

Subjective effects []

bonzi / Phenobarbital []
Routes:
  • Oral (100mg)

Experience reports

Erowid

There are currently 14 experience reports involving phenobarbital on : []

Reddit

There are currently 4 trip reports involving phenobarbital on : []

 []

  • Australia: Phenobarbital is a Schedule 4.
  • Brazil: Phenobarbital is a B1.[6]
  • Canada: Phenobarbital is a Schedule IV.
  • Germany: Phenobarbital is Prescription only/Anlage III.
  • United Kingdom: Phenobarbital is a Class B under the "Misuse of Drugs Act 1971".
  • United States: Phenobarbital is a Schedule IV under the "Controlled Substances Act".[7]
  • European Union: Phenobarbital is Prescription only.
  • Other: Phenobarbital is a SE: Förteckning IV, In general: ℞ (Prescription only).[8]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 4763, Phenobarbital. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4763
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Phenobarbital. UNII: YQE403BP4D. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/YQE403BP4D
  3. Hocker S, Clark S, Britton J. Parenteral phenobarbital in status epilepticus revisited: Mayo Clinic experience. Epilepsia. October 2018; 59 Suppl 2():193–197. PMID 30159873. https://doi.org/10.1111/epi.14488
  4. Barbiturate (Oral Route, Parenteral Route, Rectal Route) Proper Use. Mayo Clinic. 7 August 2024. https://www.mayoclinic.org/drugs-supplements/barbiturate-oral-route-parenteral-route-rectal-route/proper-use/drg-20069290
  5. Bassert JM. McCurnin's Clinical Textbook for Veterinary Technicians - E-Book. Elsevier Health Sciences. 2017. https://books.google.com/books?id=9ARODgAAQBAJ&pg=PA955
  6. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  7. Sezaby- phenobarbital sodium injection. DailyMed. 6 January 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c7d0402-4977-4c25-bc4b-11db91339e9a
  8. Fenobarbital. Läkemedelsverket. https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/substans/e4pobsu8zs2vert1/fenobarbital

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 18:01:39
drugsprook2026-11-20 18:01:35
erowidok2026-11-20 18:01:42
gsrsok2026-11-20 18:01:36
hmdbmissing (hmdb.ca refused automated access to HMDB0015305)2026-11-20 18:01:35
keggok2026-11-20 18:01:39
pubchemok2026-11-20 18:01:35
redditok2026-11-20 18:01:35
siderok2026-11-20 18:01:35
structureok2026-11-20 18:01:35
wikipediaok2026-11-20 18:01:35